Imgatuzumab (EGFR) - Research Grade Biosimilar
Product Specifications
Background
Imgatuzumab is under investigation in clinical trial NCT01326000 (A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer) .
Immunogen
Humanized / EGFR [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=10-492
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
GA201, RG7160, RO5083945
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6353944-01 0.2 mL
TBC1D3F, ID (TBC1D3F, TBC1D3E, TBC1 domain family member 3F) (FITC)
Ask
View Details 
MBS6353944-02 5x 0.2 mL
TBC1D3F, ID (TBC1D3F, TBC1D3E, TBC1 domain family member 3F) (FITC)
Ask
View Details 
